Similar articles

• Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.

  Morinan A, Collier JG. Morinan A, et al. Psychopharmacology (Berl). 1981;75(2):179-83. doi: 10.1007/BF00432184. Psychopharmacology (Berl). 1981. PMID: 6798607
• Effects of iproniazid and tranylcypromine of the half-life of N,N-dimethyltryptamine in rat brain and liver.

  Wang Lu LJ, Domino E. Wang Lu LJ, et al. Biochem Pharmacol. 1976 Jul 1;25(13):1521-7. doi: 10.1016/0006-2952(76)90071-x. Biochem Pharmacol. 1976. PMID: 1066131 No abstract available.
• Accumulation of N,N-dimethyltryptamine in rat brain cortical slices.

  Sangiah S, Gomez MV, Domino EF. Sangiah S, et al. Biol Psychiatry. 1979 Dec;14(6):925-36. Biol Psychiatry. 1979. PMID: 41604
• N,N-dimethyltryptamine--a possible relationship to schizophrenia?

  Wyatt RJ, Gillin JC, Kaplan J, Stillman R, Mandel L, Ahn HS, VandenHeuvel WJ, Walker RW. Wyatt RJ, et al. Adv Biochem Psychopharmacol. 1974;11(0):299-313. Adv Biochem Psychopharmacol. 1974. PMID: 4602668 Review. No abstract available.
• N, N-dimethyltryptamine: an endogenous hallucinogen.

  Barker SA, Monti JA, Christian ST. Barker SA, et al. Int Rev Neurobiol. 1981;22:83-110. doi: 10.1016/s0074-7742(08)60291-3. Int Rev Neurobiol. 1981. PMID: 6792104 Review. No abstract available.